Bill Clinton aims to stabilize malaria drug prices

Former President Bill Clinton's foundation has signed pricing agreements with several suppliers involved in making a malaria-fighting drug in an effort to stabilize the medication's fluctuating costs and ensure more dependable availability.

"Today's announcement is an important step forward in global efforts to increase access to affordable and effective malaria treatment," Clinton said in a statement, "and I applaud the commitments of these companies to lower volatility in this market and offer low and sustainable prices that will save more lives."

[Excerpt of an article by Sara Kugler, The Kansas City Star]